Skip to content
Saturday, January 28, 2023
Latest:
  • Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors
  • Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay
  • Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run
  • Eisai Awarded The New Diversity Management Selection 100
  • MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company
Biotech Trends Report

Biotech Trends Report

Know First, Act First

  • New Drugs & Trials
  • General
  • Leaders
  • Technology
  • Global
  • Trending

Global

BIOTCHNO Global 

Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living with Myelodysplastic Syndromes

February 16, 2021April 19, 2021 Bachittar

  Canada NewsWire REBLOZYL®, an erythroid maturation agent, is the first and only of its kind approved for use inCanada

Read more
BIOTCHNO Global 

Neptune Wellness Solutions Inc. Ships First Commercial Batch of Mood Ring(TM) Hashish in Canada

January 28, 2021April 13, 2021 vanessa

Canada NewsWire LAVAL, QC,Jan. 28, 2021/CNW Telbec/ – Neptune Wellness Solutions, Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT),

Read more
BIOTCHNO Global 

Cannara Biotech Receives Sales Licence from Health Canada

January 8, 2021April 20, 2021 vanessa

Canada NewsWire Canada to start delivering cannabis products to the Société québécoise du cannabis (SQDC) under its existing Letter of

Read more
BIOTCHNO Global 

RimotHEALTH provides screening platform to Acadian Seaplants for a safer workplace during COVID-19 pandemic and beyond

November 18, 2020April 20, 2021 vanessa

Canada NewsWire DARTMOUTH, NS, Nov. 18, 2020 Developed in Canada, RimotHEALTH is a turnkey workplace safety screening solution to further

Read more
BIOTCHNO Global 

Neptune Wellness Solutions Inc. Completes Strategic Transition from Extraction to Cannabis Consumer Packaged Goods

November 1, 2020April 20, 2021 vanessa

Canada NewsWire LAVAL, QC, Dec. 1, 2020 The Company expects the pivot to B2C branded product revenue across new categories

Read more

New Drugs & Trials

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant
BIOTCHNO New Drugs & Trials 

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant

January 20, 2021April 13, 2021 vanessa

Canada NewsWire MVMD immediately proceeding with selection of Contract Research Organization to conduct adjuvant IPV studyTORONTO,Jan. 20, 2021/CNW/ –Mountain Valley

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
BIOTCHNO New Drugs & Trials 

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease

November 19, 2020April 14, 2021 vanessa
Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
BIOTCHNO New Drugs & Trials 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 8, 2021 vanessa
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
BIOTCHNO New Drugs & Trials 

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

November 7, 2020April 15, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057